Serum γ-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors

Diabetic Medicine

Volumn 22, Issue 9, 2005, Pages 1134-1140

  Kim, D J ^a   Noh, J H ^a   Cho, N H ^b   Lee, B W ^c   Choi, Y H ^c   Jung, J H ^c   Min, Y K ^c   Lee, M S ^c   Lee, Moon Kyu ^c,d   Kim, K W ^c  

^a Inje University College of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d NONE   (South Korea)

Author keywords

glutamyltransferase; Diabetes; Korea; Metabolic syndrome

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER ENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; ECHOGRAPHY; ENZYME BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METABOLIC SYNDROME X; OBESITY; REFERENCE VALUE; SOUTH KOREA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DYSLIPIDEMIAS; FATTY LIVER; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RISK FACTORS;

EID: 24044518725     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01581.x     Document Type: Article

References (23)

1. Nemesanszky E, Lott JA. γ-Glutamyltransferase and its isoenzymes: progress and problems. Clin Chem 1985; 31: 797-803.
2. Nystrom E, Bengtsson C, Lindstedt G. Serum γ-glutamyltransferase in a Swedsh female population. Age-related reference intervals; morbidity and prognosis in cases with raised catalytic concentration. Acta Med Scand 1988; 224: 79-84.
3. Nilssen O, Forde OH, Brenn T. Distribution and population determinants of γ-glutamyltransferase. Am J Epidemiol 1990; 132: 318-326.
4. Nilssen O, Forde OH. Seven-year longitudinal population study of change in γ-glutamyltransferase: the Tromsø Study. Am J Epidemiol 1994; 139: 787-792.
5. Wannamethee G, Ebrahim S, Shaper AG. γ-Glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 1995; 142: 699-708.
6. Brenner H, Rothenbacher D, Arndt V, Schuberth S, Fraisse E, Fliedner TM. Distribution, determinants, and prognostic value of γ-glutamyltransferase for all-cause mortality in a cohort of construction workers from southern Germany. Prev Med 1997; 26: 305-307.
7. Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum γ-glutamyltransferase and risk of NIDDM. Diabetes Care 1998; 21: 732-737.
8. Miura K, Nakagawa H, Nakamura H. Serum γ-glutamyltransferase level in predicting hypertension among male drinkers. J Hum Hypertens 1994; 8: 445-449.
9. Jousilahti P, Rastenyte D, Tuomilehto J. Serum γ- glutamyltransferase, self-reported alcohol drinking, and the risk of stroke. Stroke 2000; 31: 1851-1855.
10. Marchesini G, Brizi M, Bianchi G. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850.
11. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001; 121: 91-100.
12. Ikai E, Ishizaki M, Suzuki Y, Ishida M, Noborizaka Y, Yamada Y. Association between hepatic steatosis, insulin resistance and hyperinsulinemia as related to hypertension in alcohol consumers and obese people. J Hum Hypertens 1995; 9: 101-105.
13. National Cholesterol Education Program (NCEP). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), final report. Circulation 2002; 106: 3143-3421.
14. Carol AM. General Ultrasound, 1st edn. Edinburgh: Churchill Livingstone 1992: 184-186.
15. Chitturi S, Abeygunasekera S, Farrell GC. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35: 373-379.
16. Kissebah AH. Insulin resistance in visceral obesity. Int J Obes 1991; 15: 109-115.
17. Goto T, Onuma T, Takebe K, Kral JG. The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord 1995; 19: 841-845.
18. Banerji MA, Buckley MC, Chaiken RL, Gordon D, Lebovitz HE, Kral JG. Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes Relat Metab Disord 1995; 19: 846-850.
19. Kugelman A, Choy HA, Liu R, Shi MM, Gozal E, Forman HJ. γ-Glutamyl transpeptidase is increased by oxidative stress in rat alveolar L2 epithelial cells. Am J Respir Cell Mol Biol 1994; 11: 5865-5892.
20. Takahashi Y, Oakes SM, Williams MC, Takahashi S, Miura T, Joyce-Brady M. Nitrogen dioxide exposure activates γ-glutamyl transferase gene expression in rat lung. Toxicol Appl Pharmacol 1997; 143: 388-396.
21. Karp DR, Shimooku K, Lipsky PE. Expression of γ-glutamyl transpeptidase protects ramos B cells from oxidation-induced cell death. J Bio Chem 2001; 276: 3798-3804.
22. Facchini F, Hollenbeck CB, Chen YN, Chen YD, Reaven GM. Demonstration of a relationship between white blood cell count, insulin resistance, and several risk factors for coronary heart disease in women. J Intern Med 1992; 232: 267-272.
23. Targher G, Seidell JC, Tonoli M, Muggeo M, De Sandre G, Cigolini M. The white blood cell count: its relationship to plasma insulin and other cardiovascular risk factors in healthy male individuals. J Intern Med 1996; 239: 435-441.